Bilaketaren emaitzak - Sarah Nikiforow

Findu emaitzak
  1. 1
    The unique aspects of presentation and diagnosis of hemophagocytic lymphohistiocytosis in adults

    The unique aspects of presentation and diagnosis of hemophagocytic lymphohistiocytosis in adults nork Sarah Nikiforow, Nancy Berliner

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    The why, what, and how of the new FACT standards for immune effector cells

    The why, what, and how of the new FACT standards for immune effector cells nork Marcela V. Maus, Sarah Nikiforow

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    CD4<sup>+</sup>T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation

    CD4<sup>+</sup>T-Cell Effectors Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation nork Sarah Nikiforow, Kim Bottomly, George Miller

    Argitaratua 2001
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Cytolytic CD4<sup>+</sup>-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation

    Cytolytic CD4<sup>+</sup>-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation nork Sarah Nikiforow, Kim Bottomly, George Miller, Christian Münz

    Argitaratua 2003
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50/Rta Protein Activates the Entire Viral Lytic Cycle in the HH-B2 Primary Effusion Lymphoma Cell Line

    Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50/Rta Protein Activates the Entire Viral Lytic Cycle in the HH-B2 Primary Effusion Lymphoma Cell Line nork Lyndle Gradoville, J Gerlach, Elizabeth Grogan, Duane Shedd, Sarah Nikiforow, Craig E. Metroka, George Miller

    Argitaratua 2000
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt’s Lymphoma Cells

    Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt’s Lymphoma Cells nork Casper Paludan, Kara Bickham, Sarah Nikiforow, Ming L. Tsang, Kiera Goodman, Willem A. Hanekom, Jean‐François Fonteneau, Stefan Stevanović, Christian Münz

    Argitaratua 2002
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Chimeric Antigen Receptor T-Cell Therapy–Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma

    Chimeric Antigen Receptor T-Cell Therapy–Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma nork Sarju Ganatra, Robert Redd, Salim S. Hayek, Rohan Parikh, Tariq U. Azam, Gregory A. Yanik, Lauren Spendley, Sarah Nikiforow, Caron A. Jacobson, Anju Nohria

    Argitaratua 2020
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells

    Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells nork Frederick L. Locke, Zahra Mahmoudjafari, Partow Kebriaei, Rebecca Gardner, Matthew J. Frigault, Noelle V. Frey, Krishna V. Komanduri, Miguel‐Angel Perales, Sarah Nikiforow

    Argitaratua 2025
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy

    Clinical Predictors of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy nork Daniel B. Rubin, Ali Al Jarrah, Karen Li, Sarah LaRose, Andrew D. Monk, Ali Basil Ali, Lauren Spendley, Sarah Nikiforow, Caron A. Jacobson, Henrikas Vaitkevicius

    Argitaratua 2020
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias

    Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias nork Christopher J. Gibson, James A. Kennedy, Sarah Nikiforow, Frank C. Kuo, Edwin P. Alyea, Vincent T. Ho, Jerome Ritz, Robert J. Soiffer, Joseph H. Antin, R. Coleman Lindsley

    Argitaratua 2017
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma

    Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma nork Bryan D. Choi, Elizabeth R. Gerstner, Matthew J. Frigault, Mark B. Leick, Christopher Mount, Leonora Balaj, Sarah Nikiforow, Bob S. Carter, William T. Curry, Kathleen Gallagher, Marcela V. Maus

    Argitaratua 2024
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Donor Chimerism Early after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Predicts Relapse and Survival

    Donor Chimerism Early after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Predicts Relapse and Survival nork John Koreth, Haesook T. Kim, Sarah Nikiforow, Edgar L. Milford, Philippe Armand, Corey Cutler, Brett Glotzbecker, Vincent T. Ho, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, Edwin P. Alyea

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema

    Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema nork Matthew Torre, Isaac H. Solomon, Claire L. Sutherland, Sarah Nikiforow, Daniel J. DeAngelo, Richard M. Stone, Henrikas Vaitkevicius, Ilene Galinsky, Robert F. Padera, Nikolaus S. Trede, Sandro Santagata

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Extending the Option of CMV-Specific T Cells from the CMV-Seronegative Donor

    Extending the Option of CMV-Specific T Cells from the CMV-Seronegative Donor nork Patrick J. Hanley, Sarah Nikiforow, Jan Joseph Melenhorst, Phillip Scheinberg, Barbara Savoldo, Gianpietro Dotti, Cliona M. Rooney, Helen E. Heslop, Elizabeth J. Shpall, A. John Barrett, Catherine M. Bollard

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34 <sup>+</sup> cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation

    Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34 <sup>+</sup> cell number in reduced-intensity mobilized peripheral blood allogeneic hematop... nork Paul S. Martin, Shuli Li, Sarah Nikiforow, Edwin P. Alyea, Joseph H. Antin, Philippe Armand, Corey Cutler, Vincent T. Ho, Natasha Kekre, John Koreth, Chance John Luckey, Jerome Ritz, Robert J. Soiffer

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation

    Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation nork Lindsey E. Roeker, Haesook T. Kim, Brett Glotzbecker, Prashant Nageshwar, Sarah Nikiforow, John Koreth, Philippe Armand, Corey Cutler, Edwin P. Alyea, Joseph H. Antin, Paul G. Richardson, Robert J. Soiffer, Vincent T. Ho

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

    Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? nork Matthew J. Frigault, Sarah Nikiforow, Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Marcie L. Riches, Peiman Hematti, Cameron J. Turtle, Mei-Jie Zhang, Miguel‐Angel Perales, Marcelo C. Pasquini

    Argitaratua 2020
    Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy

    Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy nork Allison Betof Warner, Omid Hamid, Krishna V. Komanduri, Rodabe N. Amaria, Marcus O. Butler, John B.A.G. Haanen, Sarah Nikiforow, Igor Puzanov, Amod A. Sarnaik, Michael Bishop, Adam J. Schoenfeld

    Argitaratua 2024
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD

    Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD nork Katie Maurer, Vincent T. Ho, Eno Inyang, Corey Cutler, John Koreth, Roman M. Shapiro, Mahasweta Gooptu, Rizwan Romee, Sarah Nikiforow, Joseph H. Antin, Catherine J. Wu, Jerome Ritz, Robert J. Soiffer, Haesook T. Kim

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease

    A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease nork Alex F. Herrera, Haesook T. Kim, Bhavjot Bindra, Kyle T. Jones, Edwin P. Alyea, Philippe Armand, Corey Cutler, Vincent T. Ho, Sarah Nikiforow, Bruce R. Blazar, Jerome Ritz, Joseph H. Antin, Robert J. Soiffer, John Koreth

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: